The ATP Binding Cassette Transporter Gene CgCDR1 from Candida glabrata Is Involved in the Resistance of Clinical Isolates to Azole Antifungal Agents
Open Access
- 1 November 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (11) , 2753-2765
- https://doi.org/10.1128/aac.43.11.2753
Abstract
The resistance mechanisms to azole antifungal agents were investigated in this study with two pairs of Candida glabrata clinical isolates recovered from two separate AIDS patients. The two pairs each contained a fluconazole-susceptible isolate and a fluconazole-resistant isolate, the latter with cross-resistance to itraconazole and ketoconazole. Since the accumulation of fluconazole and of another unrelated substance, rhodamine 6G, was reduced in the azole-resistant isolates, enhanced drug efflux was considered as a possible resistance mechanism. The expression of multidrug efflux transporter genes was therefore examined in the azole-susceptible and azole-resistant yeast isolates. For this purpose, C. glabrata genes conferring resistance to azole antifungals were cloned in a Saccharomyces cerevisiaestrain in which the ATP binding cassette (ABC) transporter genePDR5 was deleted. Three different genes were recovered, and among them, only C. glabrata CDR1 (CgCDR1), a gene similar to the Candida albicans ABC transporterCDR genes, was upregulated by a factor of 5 to 8 in the azole-resistant isolates. A correlation between upregulation of this gene and azole resistance was thus established. The deletion ofCgCDR1 in an azole-resistant C. glabrataclinical isolate rendered the resulting mutant (DSY1041) susceptible to azole derivatives as the azole-susceptible clinical parent, thus providing genetic evidence that a specific mechanism was involved in the azole resistance of a clinical isolate. When CgCDR1obtained from an azole-susceptible isolate was reintroduced with the help of a centromeric vector in DSY1041, azole resistance was restored and thus suggested that a trans-acting mutation(s) could be made responsible for the increased expression of this ABC transporter gene in the azole-resistant strain. This study demonstrates for the first time the determinant role of an ABC transporter gene in the acquisition of resistance to azole antifungals by C. glabrata clinical isolates.Keywords
This publication has 75 references indexed in Scilit:
- Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis [published erratum appears in J Antimicrob Chemother 1998 Sep;42(3):413]Journal of Antimicrobial Chemotherapy, 1998
- Cryptococcus neoformansvar. gattii- evidence for a natural habitat related to decaying wood in a pottery tree hollowMedical Mycology, 1998
- National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE ProgramDiagnostic Microbiology and Infectious Disease, 1998
- Dynamics of Candida isolations from humans from 1992–1995 in Greifswald, GermanyMycoses, 1997
- Selection ofCandida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Multiple Pdr1p/Pdr3p Binding Sites Are Essential for Normal Expression of the ATP Binding Cassette Transporter Protein-encoding GeneJournal of Biological Chemistry, 1996
- DNA macrorestriction profiles and antifungal susceptibility of Candida (Torulopsis) glabrataDiagnostic Microbiology and Infectious Disease, 1996
- Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patientsFEBS Letters, 1995
- A system for gene cloning and manipulation in the yeast Candida glabrataGene, 1994
- Correlation between in vitro susceptibility ofCandida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993